Page last updated: 2024-08-26

lysophosphatidic acid and Carcinoma, Lewis Lung

lysophosphatidic acid has been researched along with Carcinoma, Lewis Lung in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Best, B; Ramakrishnan, DP; Ren, B; Silverstein, RL; Storz, P; Walcott, BP	1

Other Studies

1 other study(ies) available for lysophosphatidic acid and Carcinoma, Lewis Lung

Article	Year
LPA/PKD-1-FoxO1 Signaling Axis Mediates Endothelial Cell CD36 Transcriptional Repression and Proangiogenic and Proarteriogenic Reprogramming. Arteriosclerosis, thrombosis, and vascular biology, 2016, Volume: 36, Issue:6 Topics: Animals; Carcinoma, Lewis Lung; CD36 Antigens; Cell Nucleus; Cells, Cultured; Cellular Reprogramming; Down-Regulation; Endothelial Cells; Ephrin-B2; Forkhead Box Protein O1; Histone Deacetylases; Humans; Lysophospholipids; Mice; Neovascularization, Pathologic; Neovascularization, Physiologic; Protein Kinase C; RNA Interference; Transcription, Genetic; Transfection	2016

Article

Year

LPA/PKD-1-FoxO1 Signaling Axis Mediates Endothelial Cell CD36 Transcriptional Repression and Proangiogenic and Proarteriogenic Reprogramming.

Arteriosclerosis, thrombosis, and vascular biology, 2016, Volume: 36, Issue:6

Topics: Animals; Carcinoma, Lewis Lung; CD36 Antigens; Cell Nucleus; Cells, Cultured; Cellular Reprogramming; Down-Regulation; Endothelial Cells; Ephrin-B2; Forkhead Box Protein O1; Histone Deacetylases; Humans; Lysophospholipids; Mice; Neovascularization, Pathologic; Neovascularization, Physiologic; Protein Kinase C; RNA Interference; Transcription, Genetic; Transfection

2016